1. Home
  2. CGEN vs HOFT Comparison

CGEN vs HOFT Comparison

Compare CGEN & HOFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • HOFT
  • Stock Information
  • Founded
  • CGEN 1993
  • HOFT 1924
  • Country
  • CGEN Israel
  • HOFT United States
  • Employees
  • CGEN N/A
  • HOFT N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • HOFT Home Furnishings
  • Sector
  • CGEN Health Care
  • HOFT Consumer Discretionary
  • Exchange
  • CGEN Nasdaq
  • HOFT Nasdaq
  • Market Cap
  • CGEN 125.3M
  • HOFT 109.2M
  • IPO Year
  • CGEN 2000
  • HOFT 1999
  • Fundamental
  • Price
  • CGEN $1.75
  • HOFT $9.12
  • Analyst Decision
  • CGEN
  • HOFT
  • Analyst Count
  • CGEN 0
  • HOFT 0
  • Target Price
  • CGEN N/A
  • HOFT N/A
  • AVG Volume (30 Days)
  • CGEN 377.9K
  • HOFT 65.6K
  • Earning Date
  • CGEN 11-11-2025
  • HOFT 09-11-2025
  • Dividend Yield
  • CGEN N/A
  • HOFT 10.02%
  • EPS Growth
  • CGEN N/A
  • HOFT N/A
  • EPS
  • CGEN N/A
  • HOFT N/A
  • Revenue
  • CGEN $22,144,000.00
  • HOFT $376,278,000.00
  • Revenue This Year
  • CGEN N/A
  • HOFT N/A
  • Revenue Next Year
  • CGEN $208.08
  • HOFT $15.15
  • P/E Ratio
  • CGEN N/A
  • HOFT N/A
  • Revenue Growth
  • CGEN N/A
  • HOFT N/A
  • 52 Week Low
  • CGEN $1.13
  • HOFT $7.34
  • 52 Week High
  • CGEN $2.66
  • HOFT $19.79
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 66.91
  • HOFT 37.08
  • Support Level
  • CGEN $1.30
  • HOFT $9.97
  • Resistance Level
  • CGEN $1.82
  • HOFT $10.74
  • Average True Range (ATR)
  • CGEN 0.11
  • HOFT 0.60
  • MACD
  • CGEN 0.05
  • HOFT -0.17
  • Stochastic Oscillator
  • CGEN 85.32
  • HOFT 0.43

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About HOFT Hooker Furnishings Corporation

Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.

Share on Social Networks: